These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 5540479

  • 1. Reversal by levodopa of cholinergic hypersensitivity in Parkinson's disease.
    Weintraub MI, Van Woert MH.
    N Engl J Med; 1971 Feb 25; 284(8):412-5. PubMed ID: 5540479
    [No Abstract] [Full Text] [Related]

  • 2. [10 years of L-DOPA therapy of Parkinson's syndrome].
    Birkmayer W.
    Wien Klin Wochenschr; 1971 Apr 02; 83(13):221-7. PubMed ID: 4254333
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of Parkinson's disease with L-dopa].
    Guglielmi L, Vecchi L.
    Clin Ter; 1970 May 15; 53(3):259-69. PubMed ID: 4917328
    [No Abstract] [Full Text] [Related]

  • 4. Dopaminergic nervous transmission in Parkinson's disease.
    Rinne UK, Sonninen V, Riekkinen P, Laaksonen H.
    Med Biol; 1974 Jun 15; 52(3):208-17. PubMed ID: 4371255
    [No Abstract] [Full Text] [Related]

  • 5. [Drug-induced Parkinson's syndrome].
    Degkwitz R.
    Dtsch Med Wochenschr; 1972 Jun 02; 97(22):882. PubMed ID: 5032182
    [No Abstract] [Full Text] [Related]

  • 6. Effect of gastric motility on levodopa.
    Fermaglich J, O'Doherty DS.
    Dis Nerv Syst; 1972 Sep 02; 33(9):624-5. PubMed ID: 4649158
    [No Abstract] [Full Text] [Related]

  • 7. [Conservative therapy in the Parkinson syndrome].
    Birkmayer W.
    Wien Med Wochenschr; 1971 Nov 13; 121(46):827-9. PubMed ID: 5138823
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Biochemical and clinical correlations in Parkinson's disease].
    Barbeau A.
    Rev Neurol (Paris); 1972 Aug 13; 127(2):253-64. PubMed ID: 4603361
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Therapeutic uses and side effects of L-dopa.
    Boshes B.
    Adv Intern Med; 1972 Aug 13; 18():219-49. PubMed ID: 4576081
    [No Abstract] [Full Text] [Related]

  • 15. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.
    Timberlake WH.
    Neurology; 1970 Dec 13; 20(12):Suppl:31-5. PubMed ID: 4921586
    [No Abstract] [Full Text] [Related]

  • 16. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
    Andrews CJ, Somerville B.
    Med J Aust; 1974 Mar 23; 1(12):429-32. PubMed ID: 4598384
    [No Abstract] [Full Text] [Related]

  • 17. Levodopa in Parkinsonism: potentiation of central effects with a peripheral inhibitor.
    Papavasiliou PS, Cotzias GC, Düby SE, Steck AJ, Fehling C, Bell MA.
    N Engl J Med; 1972 Jan 06; 286(1):8-14. PubMed ID: 4550085
    [No Abstract] [Full Text] [Related]

  • 18. Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with Parkinson's disease.
    Hauser RA, Olanow CW.
    Mov Disord; 1993 Oct 06; 8(4):512-4. PubMed ID: 8232363
    [Abstract] [Full Text] [Related]

  • 19. Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease.
    Muenter MD.
    Neurology; 1970 Dec 06; 20(12):Suppl:6-13. PubMed ID: 4921587
    [No Abstract] [Full Text] [Related]

  • 20. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.
    Timberlake WH.
    Neurology; 1970 Dec 06; 20(12):31-5. PubMed ID: 4924342
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.